14688480

Source:http://linkedlifedata.com/resource/pubmed/id/14688480

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0036667, umls-concept:C0086418, umls-concept:C0312418, umls-concept:C0683598, umls-concept:C0879272, umls-concept:C1257909, umls-concept:C1443643, umls-concept:C1521761
pubmed:issue	6
pubmed:dateCreated	2003-12-22
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/14688480-14688479
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101137842
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Boronic Acids, http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclins, http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Endopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/Multienzyme Complexes, http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin, http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein, http://linkedlifedata.com/resource/pubmed/chemical/bortezomib
pubmed:status	MEDLINE
pubmed:issn	1538-4047
pubmed:author	pubmed-author:LeeCarolynC, pubmed-author:WaldmanToddT
pubmed:issnType	Print
pubmed:volume	2
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	700-1
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:14688480-Antineoplastic Agents, pubmed-meshheading:14688480-Boronic Acids, pubmed-meshheading:14688480-Cell Line, Tumor, pubmed-meshheading:14688480-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:14688480-Cyclins, pubmed-meshheading:14688480-Cysteine Endopeptidases, pubmed-meshheading:14688480-Drug Resistance, pubmed-meshheading:14688480-Drug Tolerance, pubmed-meshheading:14688480-Gene Targeting, pubmed-meshheading:14688480-HCT116 Cells, pubmed-meshheading:14688480-Humans, pubmed-meshheading:14688480-Multienzyme Complexes, pubmed-meshheading:14688480-Protease Inhibitors, pubmed-meshheading:14688480-Proteasome Endopeptidase Complex, pubmed-meshheading:14688480-Proto-Oncogene Proteins, pubmed-meshheading:14688480-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:14688480-Pyrazines, pubmed-meshheading:14688480-Sensitivity and Specificity, pubmed-meshheading:14688480-Tumor Suppressor Protein p53, pubmed-meshheading:14688480-Ubiquitin, pubmed-meshheading:14688480-bcl-2-Associated X Protein
pubmed:articleTitle	Human somatic cell knockouts reveal determinants of sensitivity and resistance to proteasome inhibitor PS-341.
pubmed:affiliation	Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
pubmed:publicationType	Journal Article, Comment